Full-Time

Associate Director or Director

Biostatistics

Updated on 1/17/2025

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops targeted protein degradation therapies

Biotechnology
Healthcare

Senior, Expert

Belmont, MA, USA

Hybrid work model with a minimum of 3 days/week in the office.

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Python
SAS
R
Data Analysis
Requirements
  • Advanced degree in Statistics or related field with minimum 6 years of clinical trial experience in a biotechnology or pharma company.
  • Extensive knowledge of statistical methods for clinical trials and deep familiarity with FDA, EMA, and ICH guidelines.
  • Expertise in SAS required; R or Python is advantageous. Experience with trial design software such as EAST or nQuery.
  • Strong communication skills necessary for effective collaboration with cross-functional teams. Ability to communicate statistics to non-statisticians effectively; influence and ensure adoption of robust statistical methods.
  • Exceptional ability to manage multiple priorities in a fast-paced environment.
  • A strong passion for innovation in Biostatistics and continuous improvement in processes.
  • Strong analytical and problem-solving abilities.
  • Positive attitude and a collaborative spirit.
Responsibilities
  • Act as the lead statistician of a clinical program, leading statistical efforts and representing biometrics functions on program teams. Make strategic contributions to the clinical development plan.
  • Serve as the biostatistical lead for regulatory submissions and inspections, ensuring compliance with global regulatory standards.
  • Contribute to the development of clinical protocols by authoring the statistical methods section and reviewing other sections for statistical accuracy.
  • Develop and review statistical analysis plans for individual studies and integrated summaries of safety/efficacy (ISS/ISE). Create and edit statistical outputs shells.
  • Provide statistical input during CRF design to ensure alignment with study objectives and analyze requirements. Oversee and quality control results from statistical programmers or CROs.
  • Contribute to clinical study reports by authoring statistical sections and interpreting study results. Support the preparation of scientific publications and presentations.
  • Manage relationships with CROs to ensure high-quality statistical outputs and compliance with study requirements.
  • May manage direct reports, as needed, providing guidance and professional development.

Kymera Therapeutics develops treatments by targeting and breaking down specific proteins that contribute to diseases, particularly cancer and immune disorders. Their main technology, the Pegasus Platform, enables them to identify these harmful proteins and create drug candidates aimed at effectively treating various conditions. Unlike many competitors, Kymera focuses on targeted protein degradation, which can lead to more precise therapies. The company's goal is to create next-generation medicines that address unmet medical needs, supported by partnerships with organizations like Sanofi to enhance their research and development efforts.

Company Stage

IPO

Total Funding

$191.6M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Kymera raised $225M and $275M in public offerings, boosting financial resources.
  • HSBC's investment indicates strong confidence in Kymera's business model and prospects.
  • Partnership with Neosphere Biotechnologies opens new therapeutic opportunities in molecular glue discovery.

What critics are saying

  • Increased competition in protein degradation could impact Kymera's market share.
  • Regulatory scrutiny may delay clinical trials and drug approval timelines.
  • Dependence on key partnerships like Sanofi could affect revenue if altered.

What makes Kymera Therapeutics unique

  • Kymera's Pegasus Platform enables precise identification and degradation of disease-causing proteins.
  • The company focuses on targeted protein degradation, a novel approach in drug development.
  • Kymera's strategic partnership with Sanofi enhances its credibility and market reach.

Help us improve and share your feedback! Did you find this helpful?